Sen Sagnik, Damodaran Sourav, Udaya Prithviraj, Mallidi Rachana, Chandrasekar Chandralakshmi, Vallinayagam Muthukrishnan, Rajan Renu P, Kumar Karthik, Shekhar Madhu, Kannan Naresh Babu, Ramasamy Kim
Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
Department of Medical Retina, Moorfields Eye Hospital, London, UK.
Indian J Ophthalmol. 2025 Jun 1;73(6):864-869. doi: 10.4103/IJO.IJO_1700_24. Epub 2025 Apr 17.
The current study aims to assess incidence of postoperative macular edema (PME), risk factors behind PME and outcomes after cataract surgery in eyes with retinal vein occlusion (RVO).
This retrospective study included 162 eyes of 162 RVO patients, who underwent cataract surgery between 1 January 2015 and 31 December 2019. Eyes with RVO which did not have cystoid macular edema (CME) on optical coherence tomography (OCT) within the immediate 1 month prior to surgery were included.
Patients were followed up for an average duration of 13 ± 10.9 months after cataract surgery (range, 6-60 months). The mean time to PME development was 1.87 ± 1.7 months. Postoperative macular edema developed within 3 months after surgery in 40.1% of all eyes, 21% eyes with no previous CME, 57.3% of eyes with previous CME, and in 50% of eyes of patients with diabetes. Significant risk factors of PME identified were diabetes (OR = 2.1) and previous CME (OR = 4.62) requiring treatment with anti-VEGF (OR = 4.83). The visual acuity (VA) of operated eyes significantly improved from 0.85 ± 0.55 logMAR at baseline to 0.365 ± 0.39 logMAR ( P <0.0001) at the final follow-up. A significant proportion of eyes showed improvement of their VA beyond Snellen 6/12 at final follow-up ( P < 0.0001); however, eyes with PME had a higher chance of poorer vision gain (worse than 6/18). Poor prognostic factors for vision were presence of PME, previous CME and treatment history with injections, central RVO and poor VA at baseline.
The study demonstrates that RVO eyes with previous CME requiring intravitreal treatment are at significant risk of postoperative macular edema after uneventful cataract surgery, and this risk increases in people with diabetes. The incidence is not affected by the type of RVO. Considering almost 2/3 rd of PME developed within the 1 st month of surgery, we recommend a routine OCT scan as a part of postoperative assessment at the 1 st visit after surgery, in eyes at risk. Eyes developing PME may have poorer visual outcomes, especially eyes with CRVO; hence, patients need to be counseled carefully regarding outcomes of cataract surgery. The outcomes might depend on the previous treatment course they have received, and they may need to undergo a repeat cycle of treatment due to a risk of return of macular edema.
本研究旨在评估视网膜静脉阻塞(RVO)患者白内障手术后黄斑水肿(PME)的发生率、PME背后的危险因素以及手术效果。
这项回顾性研究纳入了162例RVO患者的162只眼睛,这些患者于2015年1月1日至2019年12月31日期间接受了白内障手术。纳入标准为手术前1个月内光学相干断层扫描(OCT)检查未发现黄斑囊样水肿(CME)的RVO患者。
患者在白内障手术后平均随访13±10.9个月(范围6 - 60个月)。PME发生的平均时间为1.87±1.7个月。40.1%的患眼在术后3个月内出现PME,其中无既往CME的患眼中有21%出现,有既往CME的患眼中有57.3%出现,糖尿病患者的患眼中有50%出现。确定的PME显著危险因素为糖尿病(比值比[OR]=2.1)、既往CME(OR = 4.62)以及需要抗血管内皮生长因子(VEGF)治疗(OR = 4.83)。手术眼的视力(VA)从基线时的0.85±0.55 logMAR显著提高到最终随访时的0.365±0.39 logMAR(P<0.0001)。在最终随访时,相当比例的患眼视力提高到Snellen 6/12以上(P<0.0001);然而,发生PME的患眼视力改善较差(低于6/18)的可能性更高。视力不良的预后因素包括存在PME、既往CME、注射治疗史、中心性RVO以及基线时视力差。
该研究表明,既往CME需要玻璃体腔内治疗的RVO患眼在白内障手术顺利完成后发生术后黄斑水肿的风险显著增加,糖尿病患者的这种风险更高。发病率不受RVO类型的影响。鉴于近2/3的PME在手术后第1个月内发生,我们建议对有风险的患眼在术后首次就诊时进行常规OCT扫描作为术后评估的一部分。发生PME 的患眼视力预后可能较差,尤其是中心性视网膜静脉阻塞(CRVO)的患眼;因此,需要就白内障手术的效果对患者进行仔细的咨询。手术效果可能取决于他们之前接受的治疗过程,并且由于黄斑水肿复发的风险,他们可能需要接受重复治疗周期。